ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

Solomon Garb’s Questions/Answers

December 19, 1980

NCCS Networker Volume 4 Issue 3, Summer 1990

June 13, 1990

Lagging Government Salaries Spur NCI Turnover Among Senior Staff, Threaten Cancer Program

September 5, 1975

NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’

March 8, 1991